Taken together, our findings suggest that PDX and nephrin may serve as complementary diagnostic tools to current methods, especially in challenging cases such as high PPROM, with the possibility of broader clinical adoption if validated in larger multicenter studies. This evidence concerns the gene NPHS1 and preterm premature rupture of the membranes.